Search Results

There are 4457 results for: content related to: Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study

  1. You have free access to this content
    Ropinirole, a Non-Ergoline Dopamine Agonist

    CNS Drug Reviews

    Volume 11, Issue 3, September 2005, Pages: 253–272, Wolfgang H. Jost and Dieter Angersbach

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2005.tb00046.x

  2. Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson’s disease

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 571–577, N. Hattori, K. Hasegawa and T. Sakamoto

    Article first published online : 6 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01336.x

  3. Ropinirole for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001516

  4. Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1627–1635, Jacques Montplaisir, Jeff Karrasch, Jean Haan and Dieter Volc

    Article first published online : 27 JUL 2006, DOI: 10.1002/mds.21050

  5. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  6. DA agonists - Non-Ergot derivaties: Ropinirole

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S98–S102,

    Article first published online : 29 JUL 2002, DOI: 10.1002/mds.5570

  7. Lack of a Pharmacokinetic Interaction at Steady State Between Ropinirole and L-Dopa in Patients with Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 2, February 1999, Pages: 150–156, Dr. Anne C. Taylor, Dr. Almisbah Beerahee, Dr. David R. Citerone, Dr. Matthew J. Cyronak, Dr. Terry J. Leigh, Dr. Katherine L. Fitzpatrick, Dr. Arturo Lopez-Gil, Dr. Sarosh D. Vakil, Dr. Eileen Burns and Dr. Graham Lennox

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.19.3.150.30927

  8. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease

    Movement Disorders

    Volume 24, Issue 14, 30 October 2009, Pages: 2121–2127, Kelly E. Lyons and Rajesh Pahwa

    Article first published online : 18 SEP 2009, DOI: 10.1002/mds.22750

  9. PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

    Movement Disorders

    Volume 26, Issue 7, June 2011, Pages: 1259–1265, Fabrizio Stocchi, Luigi Giorgi, Brian Hunter and Anthony HV Schapira

    Article first published online : 5 APR 2011, DOI: 10.1002/mds.23498

  10. You have free access to this content
    Interactions between domperidone and ropinirole, a novel dopamine D2- receptor agonist.

    British Journal of Clinical Pharmacology

    Volume 32, Issue 4, October 1991, Pages: 483–488, C de Mey, D Enterling, I Meineke and S Yeulet

    Article first published online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1991.tb03935.x

  11. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 631–641, Eleni C. Maratos, Michael J. Jackson, Ronald K. B. Pearce and Peter Jenner

    Article first published online : 11 JUL 2001, DOI: 10.1002/mds.1149

  12. A single and multiple dose study to investigate the pharmacokinetics of a prolonged release formulation of ropinirole in healthy Chinese subjects

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 2, March/April 2014, Pages: 84–92, Hongzhong Liu, Ji Jiang, Hongyun Wang, Xia Chen, Tao Liu, Haijun Cao, Jonathan Palmer, Anita Gu and Pei Hu

    Article first published online : 30 OCT 2013, DOI: 10.1002/cpdd.28

  13. A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease

    Movement Disorders

    Volume 22, Issue 4, 15 March 2007, Pages: 476–482, Carlos Singer, Janice Lamb, Amanda Ellis and Gary Layton

    Article first published online : 22 FEB 2007, DOI: 10.1002/mds.21361

  14. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study

    Movement Disorders

    Volume 13, Issue 1, January 1998, Pages: 46–51, Prof. Amos D. Korczyn, David J. Brooks, Ehrout R. Brunt, Warner H. Poewe, Olivier Rascol and Fabrizzio Stocchi

    Article first published online : 4 NOV 2004, DOI: 10.1002/mds.870130112

  15. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Katherine Deane

    Published Online : 22 JAN 2001, DOI: 10.1002/14651858.CD001517

  16. Effect of Ropinirole on Sleep Outcomes in Patients with Restless Legs Syndrome: Meta-Analysis of Pooled Individual Patient Data from Randomized Controlled Trials

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 3, March 2009, Pages: 255–262, Dr. Richard A. Hansen, Dr. Liping Song, Dr. Charity G. Moore, Dr. Alicia W. Gilsenan, Dr. Mimi M. Kim, Dr. Michael O. Calloway and Dr. Michael D. Murray

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.3.255

  17. Development of dyskinesias in a 5-year trial of ropinirole and L-dopa

    Movement Disorders

    Volume 21, Issue 11, November 2006, Pages: 1844–1850, Olivier Rascol, David J. Brooks, Amos D. Korczyn, Peter P. De Deyn, Carl E. Clarke, Anthony E. Lang and Mona Abdalla

    Article first published online : 6 SEP 2006, DOI: 10.1002/mds.20988

  18. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom Disease): Results from a prospective, multicenter study over 66 weeks

    Movement Disorders

    Volume 27, Issue 2, February 2012, Pages: 277–283, Diego García-Borreguero, Birgit Högl, Luigi Ferini-Strambi, John Winkelman, Christina Hill-Zabala, Afsaneh Asgharian and Richard Allen

    Article first published online : 4 JAN 2012, DOI: 10.1002/mds.24889

  19. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

    Movement Disorders

    Volume 22, Issue 16, 15 December 2007, Pages: 2409–2417, Robert A. Hauser, Olivier Rascol, Amos D. Korczyn, A. Jon Stoessl, Ray L. Watts, Werner Poewe, Peter P. De Deyn and Anthony E. Lang

    Article first published online : 25 SEP 2007, DOI: 10.1002/mds.21743

  20. Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole

    Movement Disorders

    Volume 22, Issue 16, 15 December 2007, Pages: 2398–2404, Nir Giladi, Babak Boroojerdi, Amos D. Korczyn, David J. Burn, Carl E. Clarke and Anthony H.V. Schapira

    Article first published online : 12 OCT 2007, DOI: 10.1002/mds.21741